日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study

来自 KEYNOTE-671 随机研究的围手术期帕博利珠单抗治疗 II 期非小细胞肺癌的亚组分析

Tsuboi, Masahiro; Wakelee, Heather; Garassino, Marina C; Gao, Shugeng; Luft, Alexander; Chen, Ke-Neng; Spicer, Jonathan D; Zhu, Yuming; Saji, Hisashi; Okada, Morihito; Vanakesa, Tõnu; Chen, Haiquan; Zhao, Guofang; Ikeda, Norihiko; Jones, David R; Weksler, Benny; Huang, Chien-Sheng; Jensen, Erin; Keller, Steven M; Samkari, Ayman; Liberman, Moishe

Analysis of molecular subtypes and prognostic signature of senescence-associated secretory phenotype in pancreatic cancer

胰腺癌衰老相关分泌表型的分子亚型及预后特征分析

Kuang, Yuewen; Jia, Mingkun; Zhu, Yuming; Xiang, Zhiyong

Artificial intelligence driven 3D reconstruction for enhanced lung surgery planning

利用人工智能驱动的三维重建技术改进肺部手术规划

Chen, Xiuyuan; Dai, Chenyang; Peng, Muyun; Wang, Dawei; Sui, Xizhao; Duan, Liang; Wang, Xiang; Wang, Xun; Weng, Wenhan; Wang, Shaodong; Zhao, Heng; Wang, Zhenfan; Geng, Jiayi; Chen, Chen; Hu, Yan; Hu, Qikang; Jiang, Chao; Zheng, Hui; Bao, Yi; Sun, Chao; Cui, Zhuoer; Zeng, Xiangyu; Han, Huiming; Xia, Chen; Liu, Jinlong; Yang, Bing; Qi, Ji; Ji, Fanghang; Wang, Shaokang; Hong, Nan; Wang, Jun; Chen, Kezhong; Zhu, Yuming; Yu, Fenglei; Yang, Fan

Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial

新辅助奥莫替尼治疗不可切除的III期EGFR突变型非小细胞肺癌:一项单臂II期试验

Bian, Dongliang; Ji, Shuyu; Liu, Yue; Huang, Zhida; Jiang, Lei; Liu, Ming; Bao, Xiao; Yang, Jie; Zhou, Yirui; Hu, Junjie; Sun, Liangdong; Zheng, Yingzhi; Huang, Jie; Liu, Jing; Zhu, Xinsheng; Zhang, Jing; Zhang, Lele; Liu, Xiaogang; He, Wenxin; Xie, Dong; Zhu, Yuming; Wu, Chunyan; Zhao, Deping; Duan, Liang; Jiang, Gening; Zhang, Peng

Efficiency and safety of sintilimab-based induction therapy in potentially resectable stage III non-small cell lung cancer (LungMate-009): an open-label, phase 2 trial

信迪利单抗诱导治疗在潜在可切除的 III 期非小细胞肺癌中的疗效和安全性(LungMate-009):一项开放标签的 II 期试验

Ge, Tao; Zhang, Hongyi; Zhu, Xinsheng; Teng, Meixin; Zhou, Yifei; Wang, Suyu; Bian, Dongliang; Zhang, Lele; Hu, Haiyang; Guo, Qiji; Su, Jincheng; Hu, Shiqi; Yu, Huansha; Zhou, Yirui; Huang, Jie; Yang, Jie; Zhu, Yuming; Bao, Yi; Bao, Minwei; Hu, Xuefei; He, Wenxin; Zhang, Peng

Patterns of left ventricular trabeculation in hypertrophic cardiomyopathy

肥厚型心肌病左心室小梁形成模式

Zhang, Yu; Zhou, Di; Zhu, Yuming; Huang, Qiya; Wang, Jizheng; Zhang, Channa; Kang, Lianming; Lu, Minjie; Song, Lei

Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA-IIIA NSCLC: a multicenter, two-arm, phase II exploratory trial

新辅助卡瑞利珠单抗联合化疗或阿帕替尼治疗可切除的 IIA-IIIA 期非小细胞肺癌:一项多中心、双臂、II 期探索性试验

Ji, Shuyu; Sheng, Zhenxin; Bian, Dongliang; Bao, Minwei; Jin, Kaiqi; Zhang, Wentian; Zhu, Xinsheng; Sun, Fenghuan; Xia, Haoran; Zhang, Han; Shen, Ziyun; Yu, Huansha; Zhang, Lele; Huang, Jie; Peng, Zhang; Song, Nan; Wang, Haifeng; Qian, Biyun; Zhu, Yuming

Oral microbiome between patients with non-obstructive and obstructive hypertrophic cardiomyopathy

非阻塞性肥厚型心肌病患者与阻塞性肥厚型心肌病患者的口腔微生物组差异

Qin, Qianyi; Zhu, Yuming; Yang, Liu; Guo, Runzhi; Song, Lei; Wang, Dong; Li, Weiran

Role of artificial intelligence in medical image analysis

人工智能在医学图像分析中的作用

Wang, Lu; Zhang, Shimin; Xu, Nan; He, Qianqian; Zhu, Yuming; Chang, Zhihui; Wu, Yanan; Wang, Huihan; Qi, Shouliang; Zhang, Lina; Shi, Yu; Qu, Xiujuan; Zhou, Xin; Song, Jiangdian

Selective inhibition of TGF-β-induced epithelial-mesenchymal transition overcomes chemotherapy resistance in high-risk lung squamous cell carcinoma.

选择性抑制 TGF-β 诱导的上皮-间质转化可克服高危肺鳞状细胞癌的化疗耐药性

Sun Liangdong, Wang Jue, Yu Huansha, Zhu Xinsheng, Zhang Jing, Hu Junjie, Yan Yilv, Zhang Xun, Zhu Yuming, Jiang Gening, Ding Ming, Zhang Peng, Zhang Lele